We studied 44 patients undergoing carotid endarterectomy (CEA) to compare recovery after general anaesthesia with des¯urane supplemented with either remifentanil or fentanyl. Remifentanil was infused at 0.1 mg kg ±1 min ±1 and des¯urane was adjusted at 2 vol% end-tidal. Fentanyl was given as a bolus dose of 2 mg kg ±1 before induction and repeated at skin incision; des¯urane was adjusted as needed. Times for early recovery and response to simple neurological tests (digit symbol substitution test (DSST) and Trieger dot test (TDT)) were measured 30, 60 and 90 min after operation. Emergence from remifentanil±des¯urane anaesthesia was signi®cantly quicker than that from fentanyl±des¯urane anaesthesia: mean times to extubation were 4.1 (SD 1.7) and 8.2 (4.9) min, respectively; mean times for patients to state their name correctly were 6.0 (2.8) and 13.8 (9.0) min, respectively. Patients in the remifentanil±des¯urane group successfully performed neurological tests signi®cantly earlier than those in the fentanyldes¯urane group; for example, patients in the former group completed the arm holding test at 7.9 (3.0) min, while those in the latter group did this at 20.6 (19.7) min (P`0.01). Intermediate recovery was less impaired at 30 min (DSST, TDT) and at 60 min (DSST). More rapid awakening and an earlier opportunity for neurological examination suggest that remifentanil±-des¯urane is a suitable alternative to a standard fentanyl-based general anaesthetic technique in patients undergoing CEA. Carotid artery surgery carries the risk of substantial complications; in some cases (such as dissection, thrombosis or haemorrhage), the damage can be reduced if complications are diagnosed early and treated promptly.
Therefore, rapid recovery and early neurological assessment are useful goals in the anaesthetic management of patients undergoing carotid endarterectomy (CEA). The combination of short-acting anaesthetics such as remifentanil and des¯urane may be superior to a standard fentanyl general anaesthetic technique. We compared early and neurological testing of patients undergoing elective CEA who were randomly assigned to receive general anaesthesia with remifentanil±des¯urane or fentanyl-des¯urane.
Patients and methods

Preinduction
With institutional review board approval and written informed consent, we enrolled 44 adult male and female patients in a prospective randomized two-group study. All patients were classi®ed as ASA physical status II or III and scheduled for elective CEA because of a narrowing of the carotid artery lumen of b80% in asymptomatic or b70% in symptomatic patients. Exclusion criteria were a history of any disabling central nervous disease, hypersensitivity to opioids or substance abuse, or a treatment with opioids or any psychoactive medication. After enrollment patients were randomized by drawing lots from a closed box.
Induction and maintenance
On the morning of surgery, all patients were given 5 mg of diazepam orally 90 min before induction. In the operating room, two intravenous catheters were inserted and the radial artery was cannulated. Standard monitors were applied. Before induction, all patients were given 5 ml kg ±1 of a 3% gelatin infusion intravenously.
In the fentanyl±des¯urane group, induction started with a dose of fentanyl 2 mg kg ±1 . Five minutes later etomidate was given for hypnosis, initially starting at 0.15 mg kg ±1 and then at 2 mg every 10 s until the patient was unresponsive to verbal command. The des¯urane vaporizer was then set to 3 vol% and ventilation with des¯urane in oxygen was given as required. Patients were then given 0.1 mg kg ±1 of cisatracurium, the trachea was intubated 3 min later and the lungs were ventilated to achieve normocapnia, using des¯urane and 66% nitrous oxide in oxygen. Five minutes before skin incision, another 2 mg kg ±1 bolus dose of fentanyl was injected and des¯urane was added as needed for maintenance, starting at an end-tidal concentration of 4 vol% (=2/3 MAC).
In the remifentanil±des¯urane group, all patients were given atropine 5 mg kg ±1 followed by remifentanil 1 mg kg ±1 , injected over 30 s, and an infusion of remifentanil was started simultaneously at 0.1 mg kg ±1 min ±1 . Five minutes later, etomidate was given, followed by des¯urane and cisatracurium as described above. Five minutes after intubation remifentanil was reduced to 0.05 mg kg ±1 min
±1
and then readjusted to 0.1 mg kg ±1 min ±1 3 min before skin incision. Maintenance of anaesthesia consisted of remifentanil infused at 0.1 mg kg ±1 min ±1 , with des¯urane added to obtain an end-tidal concentration of 2 vol% (=1/3 MAC).
In both groups, according to our department's policy, nitrous oxide was discontinued 5 min before the carotid artery was cross-clamped; the lungs were then ventilated with des¯urane in oxygen until the end of the operation.
Monitoring and haemodynamic control
Continuous monitoring included heart rate (HR), systemic arterial pressure, respiratory rate, oxygen saturation and end-tidal concentrations of carbon dioxide and des¯urane. Arterial blood gases were analysed intermittently and the Pa CO 2 was maintained between 4.8±5.9 kPa (36±44 mm Hg). The oxygen saturation was measured by pulse oximetry and maintained above 95%. Transcranial Doppler ultrasound was continuously applied, by a neurologist (M.M.), to the ipsilateral middle cerebral artery to measure mean blood velocity during surgery and crossclamping (for the exact technique see ref. 4) .
Baseline systolic arterial pressure (SAP) was de®ned as the lower of the two measurements obtained the day before surgery and immediately before induction of anaesthesia. The de®nition of adverse haemodynamic responses was adapted from Garrioch and Fitch:
1 responses of b1 min of duration were classi®ed as`hypertension' (SAP>40 mm Hg from baseline or >200 mm Hg),`hypotension' (SAP<40 mm Hg from baseline or <100 mm Hg),`tachycardia' (HR>100 beats min ±1 ) and`bradycardia' (HR<45 beats min ±1 ). Inadequate anaesthesia was de®ned as hypertension, tachycardia or patient movement, eye opening, swallowing, grimacing, lacrimation or sweating.
In the fentanyl±des¯urane group, if anaesthesia was inadequate the end-tidal des¯urane concentration was increased in steps of 0.5 vol% as necessary. If this was judged insuf®cient, then an additional bolus dose of 0.5 mg kg ±1 fentanyl could be injected. Hypotension was initially treated with i.v.¯uid replacement; des¯urane was then reduced in steps of 0.5 vol%, and ®nally, an i.v. vasopressor (cafedrine/theodrenaline) was given at a dose chosen by the investigator. In the remifentanil±des¯urane group, if anaesthesia was inadequate the infusion rate was increased by 0.05 mg kg ±1 min ±1 or a bolus dose of 1 mg kg ±1 was injected; both interventions were repeated as necessary.
If this was insuf®cient, des¯urane was increased by 0.5 vol% end-tidal. Hypotension was initially treated with i.v. uids; the remifentanil infusion rate was then reduced to a permitted minimum of 0.05 mg kg ±1 min ±1 ; ®nally, an i.v. vasopressor was used as described above. In both groups bradycardia was treated with 0.25 mg of atropine.
Recovery period
Fifteen minutes before the expected end of surgery, complete neuromuscular recovery was ensured by neuromuscular monitoring; all patients received a 100 ml infusion of 0.9% NaCl containing metamizol 25 mg kg ±1 for postoperative pain relief. The end of surgery was de®ned as the ®nal surgical suture, when anaesthetic delivery was stopped. During recovery, a post-anaesthetic recovery score (PARS), as de®ned by Aldrete and Kroulik, 5 was recorded continuously. Oxygenation was maintained by intermittent positive pressure ventilation using a fresh gas¯ow of 10 litres min ±1 of 100% oxygen until spontaneous respiration returned. Emergence from anaesthesia was assessed by measuring the times to return of spontaneous ventilation, extubation, response to verbal command (opening eyes, stating name and date of birth) and when the Aldrete score became 9 or above.
All patients were then moved to the post-anaesthesia care unit (PACU), where observation was continued by an investigator and a PACU nurse, neither of whom was aware of the anaesthetic regimen. If further pain relief was requested, patients could be given bolus doses of 3 mg piritramide at the discretion of the attending nurse. Each patient was continuously observed for neurological de®cits, and the times (expressed as minutes from end of surgery) taken for the patient to be able to perform the arm and the leg holding tests were recorded. The depth of sedation was assessed for the ®rst 60 min after the end of surgery using a ®ve-point scale for observer assessment of alertness/ sedation: 1=asleep, unarousable; 2=asleep, dif®cult to rouse; 3=asleep, easy to rouse; 4=awake and calm; 5=awake but anxious.
Intermediate recovery was assessed by the Trieger dot test (TDT), in which individuals are asked to connect a series of 50 dots of a geometrical ®gure, 6 and by the digit symbol substitution test (DSST), in which individuals are asked to match numbers with prede®ned symbols during a 120 s period (adapted from refs 7 and 8 ). All patients had completed a ®rst series of these tests on the day before surgery, with the results serving as baseline values. Thirty, 60 and 90 min after the end of surgery, both tests were repeated; the results are expressed as a percentage of baseline.
End-points and statistical analysis
The primary end-point of this study was de®ned as the time taken to respond to verbal command (state the correct name). Applying an a priori power analysis, at least 17 patients had to be enrolled in each treatment group to provide 80% power to detect a difference of 3 min at a=0.05. Statistical analysis was performed by means of the Mann±Whitney U-test for numerical data and Fisher's exact test for nominal data. All tests were two-tailed with statistical signi®cance de®ned as P<0.05; data are presented as mean and standard deviation (SD) in the tables or standard error (SEM) in the ®gures. Statistical analysis was planned and performed in collaboration with a statistician of the Institute of Medical Biometrics, Epidemiology and Informatics, University of Saarland, using SPSS computer software (version 7.5.2G; SPSS Inc.).
Results
Forty-four patients were enrolled in this study (23 in the remifentanil group and 21 in the fentanyl group); the groups were similar with respect to age, weight, height, ASA physical status and duration of surgery (Table 1) . With remifentanil, less etomidate was necessary to achieve a loss of consciousness during induction of anaesthesia. At the end of surgery, the mean end-tidal des¯urane concentration was signi®cantly lower (1.9 (SD 0.2) vol%) than with fentanyl (3.5 (1.4) vol%). Carotid artery cross-clamping times were similar in both groups but, by chance, signi®cantly more patients with remifentanil±des¯urane had surgery on the left (dominant hemisphere) side.
Overall, haemodynamic responses (i.e. the courses of HR and mean arterial pressure) were similar for both treatment groups: mean arterial pressure did not differ throughout surgery and was signi®cantly less with remifentanil than with fentanyl only immediately before and 1 min after intubation (Table 2) . Intervention with a vasopressor (cafedrine/theodrenaline) was used in 70% of all patients (78% with remifentanil, 62% with fentanyl (P=0.33)) and there was no difference in the amount of drug given per treated patient (0.92 (0.61) or 0.92 (0.43) ml). 
Recovery period
After awakening, a major stroke was found in one patient in each treatment group. Consequently, early recovery times were recorded for 22 patients in the remifentanil group and for 20 patients in the fentanyl group. Apart from the onset of spontaneous ventilation, recovery times were signi®cantly shorter after remifentanil±des¯urane: tracheal extubation was possible sooner and patients could open their eyes sooner and state their name and date of birth correctly sooner. Neurological tests could be carried out signi®cantly earlier ( Table 3) . The sedation score showed that patients after remifentanil±des¯urane anaesthesia were signi®cantly more alert than those after fentanyl±des¯urane anaesthesia, and a signi®cant difference was noted even 60 min after the end of surgery (Figure 1 ).
Psychomotor and cognitive performance was assessed by DSST and TDT scores in 20 patients in each group. Two patients in the remifentanil group could not be investigated: one patient underwent surgical treatment for super®cial wound bleeding, and another refused to participate in that part of the study. Both tests showed an initial decrease from baseline values and than progessively improved during the period of emergence. Following remifentanil±des¯urane anaesthesia, DSST and TDT were impaired signi®cantly less at 30 min (DSST, TDT) and 60 min (DSST) after anaesthesia (Figures 2 and 3 ).
Discussion
We found that patients undergoing carotid artery surgery after remifentanil±des¯urane anaesthesia recovered more quickly than those given a`traditional' general anaesthetic technique with intermittent bolus doses of supplemental fentanyl. This acceleration of recovery is not limited to the initial period of awakening from anaesthesia; it also allows earlier neurological examination and is still shown in the ®rst hour after surgery with a more rapid return of psychomotor and cognitive functions.
These results are of current interest since CEA is increasingly being performed in patients with carotid stenosis, and randomized clinical studies have shown that strokes can be reduced. 9 However, CEA may cause postoperative neurological de®cits, which should be diagnosed and treated promptly. In some techniques, the use of opioids is reduced whenever possible to allow rapid postoperative awakening and early neurological assessment. 2 Other techniques use an opioid-based anaesthetic because of the prevalence of co-existing coronary artery disease in these patients. 1 Remifentanil is rapidly broken down by non-speci®c esterases to nearly inactive metabolites, so recovery from intraoperative opioid analgesia can be rapid. 10 After remifentanil, about 2 min elapsed from the onset of spontaneous ventilation to the moment that patients could state their name and date of birth correctly, and 2 min later The properties of remifentanil allow high-dose opioid use throughout the operation, and reduce the amount of des¯urane needed, which is a reason for the difference in recovery seen when remifentanil is used. The impact of the amount of the inhaled anaesthetic on awakening from anaesthesia is known from animal and human studies: Eger and Johnson 11 investigated rats that were anaesthetized for 2 h with different volatile anaesthetics and at different multiples of their MAC values. Awakening was typically most rapid with the lowest concentration of the inhaled anaesthetic; this also applies to the results of our study: At the end of surgery, the mean end-tidal des¯urane concentration was 3.5 vol% in the fentanyl group, but only 1.9 vol% in the remifentanil group. Similar results were obtained by Smiley and co-workers 12 in patients undergoing elective surgery with des¯urane or iso¯urane anaesthesia with 0.65Q or 1.25QMAC: recovery was faster with the lower anaesthetic concentration.
In addition to the difference in des¯urane concentration, the opioid itself will in¯uence the time course of awakening. Glass and colleagues 13 argued that only small amounts of fentanyl or remifentanil are necessary to reduce the MAC, and this also applies to the alveolar concentration of the volatile anaesthetic, at which patients will awake from anaesthesia. Thus, the duration of pharmacodynamic interaction will depend on the duration of the opioid effect; this will clearly be longer with fentanyl than with remifentanil.
A similar anaesthetic technique was proposed by Gerhardt and Grichnik 3 who reported the use of remifentanil in a 60 yr old patient undergoing combined CEA and coronary artery bypass grafting. Their dosage regimen was nearly identical to ours: a remifentanil infusion was titrated to clinical needs and 1/3 MAC (i.e. 0.4 vol%) of iso¯urane was added (we used 1/3 MAC of des¯urane, i.e. 2 vol%).
The authors concluded that remifentanil may retain the haemodynamic stability of an opioid-based anaesthetic technique while allowing for early extubation and neurological examination.
A potential shortcoming of the present study is the question of equivalent levels of anaesthesia in the two groups. The dosage regimens used in this study are comparable to that of other remifentanil-based anaesthesia studies and have been empirically effective. All anaesthetics were delivered by the same experienced anaesthesiologist, who relied on standard clinical signs as described iǹ Patients and methods'. Apart from a better reduction in the haemodynamic response to intubation with remifentanil, the haemodynamic characteristics were very similar in the two groups (Table 2 ). This suggests the equivalence of anaesthesia in the two treatment groups, especially at the end of surgery when the assessment of recovery characteristics was started.
In conclusion, rapid postoperative awakening, quicker recovery and earlier neurological examination suggest that remifentanil±des¯urane is a suitable alternative to fentanyl±des¯urane as a general anaesthetic for patients undergoing carotid artery surgery.
